Trustee Appointed for the Arbitration Proceedings Concerning the Redemption of Minority Shares in Nixu
Nixu Corporation, Stock Exchange Release, August 17, 2023, 7.00 p.m. EETDNV AS (“DNV”) has on June 16, 2023, commenced redemption proceedings in respect of Nixu Corporation’s (“Nixu”) minority shares by initiating arbitration proceedings in accordance with Chapter 18, Section 3 of the Finnish Companies Act (624/2006, as amended, the “Finnish Companies Act”) in order to obtain ownership of all the issued and outstanding shares in Nixu. Due to DNV’s application for the above-mentioned arbitration proceedings, the Redemption Committee of the Finland Chamber of Commerce has petitioned the
Located in Franklin, Kentucky, RKW North America is one of the leading manufacturers of sustainable, high-performance films for a wide range of applications across North America. Founded in 2000 as Danafilms Inc., the company became part of the RKW Group in late 2010, an independent family owned company headquartered in Germany with more than 65 years of experience in manufacturing excellent film solutions. The RKW Group operates 17 sites on four continents.
For over two decades, RKW North America has been producing high-performance mono and multi-layer films for the converting industry.
The Ball Valve 523 Pro and Ball Valve 546 Linear Pro have joined the Swiss flow solution provider’s growing product family of state-of-the-art and interoperable solutions for Process Automation. The line-up features corrosion-free materials, a simple and reliable operation, as well as various actuation options.Ball Valves are an essential part of every piping system and come in a variety of sizes, materials, and actuation technologies. They are used to regulate, mix, or distribute media in applications ranging from water treatment and desalination all the way to complex chemical and
Stockholm, August 17, 2023 - Intervacc AB (publ) announces that it has been awarded an “industrial research” grant from Vinnova as part of a project with Testa Center, Uppsala, Sweden, to optimise the manufacturing processes of one component for a prototype vaccine for pigs.
Intervacc’s innovative technology utilises fusion proteins in vaccines to generate broad-acting immune responses that provide protection to animals from complex bacterial diseases. Streptococcus suis causes meningitis, sepsis and arthritis in young piglets, leading to significant costs to the pig industry throughout
